Jennifer Jarrett, Chief Operating Officer of Arcus Biosciences ($RCUS), sold about $2.17 million worth of company shares in five open market transactions over the past year. Her most recent sale occurred on December 17, 2025. These sales rank 3,332nd among 11,678 individual insiders in our database, where the average is $8.59 million across 6.37 transactions. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 30, 2026 | Damora Therapeutics, Inc. | $DMRA | Jarrett Jennifer | See Remarks | A | Common Stock | 500000 | $0.00 | 500,000.0000 | 1,327,212 | 9999.99% | 37.67% |
| March 30, 2026 | Damora Therapeutics, Inc. | $DMRA | Jarrett Jennifer | See Remarks | A | Stock Option (right to buy) | 1500000 | $0.00 | 1,500,000.0000 | 1,327,212 | 9999.99% | 100.00% |
| Feb. 4, 2026 | Syndax Pharmaceuticals Inc | $SNDX | Jarrett Jennifer | Not found | A | Common Stock | 24000 | $0.00 | 114,000.0000 | 86,914,838 | 26.67% | 0.03% |
| Jan. 23, 2026 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | A | Stock Option (right to buy) | 126000 | $0.00 | 126,000.0000 | 107,973,536 | 9999.99% | 0.12% |
| Jan. 23, 2026 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | A | Common Stock | 31000 | $0.00 | 224,024.0000 | 107,973,536 | 16.06% | 0.03% |
| Dec. 16, 2025 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | S | Common Stock | 11225 | $21.88 | 203,007.0000 | 107,973,536 | 5.24% | 0.01% |
| Dec. 17, 2025 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | S | Common Stock | 9983 | $22.16 | 193,024.0000 | 107,973,536 | 4.92% | 0.01% |
| Nov. 7, 2025 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | S | Common Stock | 50291 | $18.97 | 214,232.0000 | 107,973,536 | 19.01% | 0.05% |
| Nov. 7, 2025 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | M | Stock Option (Right to Buy) | 50291 | $1.23 | 80,583.0000 | 107,973,536 | 38.43% | 0.05% |
| Nov. 7, 2025 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | M | Common Stock | 50291 | $1.23 | 264,523.0000 | 107,973,536 | 23.48% | 0.05% |
| Oct. 6, 2025 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | S | Common Stock | 12500 | $14.54 | 214,232.0000 | 105,841,422 | 5.51% | 0.01% |
| Oct. 8, 2025 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | M | Stock Option (Right to Buy) | 37792 | $0.00 | 130,874.0000 | 105,841,422 | 22.41% | 0.04% |
| Oct. 6, 2025 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | M | Stock Option (Right to Buy) | 12500 | $0.00 | 168,666.0000 | 105,841,422 | 6.90% | 0.01% |
| Oct. 8, 2025 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | S | Common Stock | 37792 | $15.05 | 214,232.0000 | 105,841,422 | 15.00% | 0.04% |
| Oct. 8, 2025 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | M | Common Stock | 37792 | $1.23 | 252,024.0000 | 105,841,422 | 17.64% | 0.04% |
| Oct. 6, 2025 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | M | Common Stock | 12500 | $1.23 | 226,732.0000 | 105,841,422 | 5.83% | 0.01% |
| June 9, 2025 | Sagimet Biosciences Inc. | $SGMT | Jarrett Jennifer | Director | A | Stock Option (Right to Buy) | 27268 | $0.00 | 27,268.0000 | 32,195,345 | 9999.99% | 0.08% |
| May 21, 2025 | Zura Bio Ltd | $ZURA | Jarrett Jennifer | Not found | A | Share Option (Right to Buy) | 51000 | $0.00 | 51,000.0000 | 92,964,048 | 9999.99% | 0.05% |
| Feb. 5, 2025 | Syndax Pharmaceuticals Inc | $SNDX | Jarrett Jennifer | Not found | A | Common Stock | 25000 | $0.00 | 90,000.0000 | 0 | 38.46% | 0.00% |
| Jan. 23, 2025 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | A | Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2025 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | A | Common Stock | 50000 | $0.00 | 213,369.0000 | 0 | 30.61% | 0.00% |
| Dec. 15, 2024 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | F | Common Stock | 27501 | $16.08 | 163,369.0000 | 0 | 14.41% | 0.00% |
| Dec. 9, 2024 | Zura Bio Ltd | $ZURA | Jarrett Jennifer | Not found | A | Share Option (Right to Buy) | 117000 | $0.00 | 117,000.0000 | 87,335,667 | 9999.99% | 0.13% |
| Sept. 15, 2024 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | F | Common Stock | 12670 | $17.95 | 190,394.0000 | 0 | 6.24% | 0.00% |
| Aug. 1, 2024 | Sagimet Biosciences Inc. | $SGMT | Jarrett Jennifer | Director | A | Stock Option (Right to Buy) | 113895 | $0.00 | 113,895.0000 | 31,913,887 | 9999.99% | 0.36% |
| June 15, 2024 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | F | Common Stock | 12670 | $16.97 | 203,064.0000 | 0 | 5.87% | 0.00% |
| March 27, 2024 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | S | Common Stock | 11551 | $17.55 | 215,253.0000 | 0 | 5.09% | 0.00% |
| March 18, 2024 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | S | Common Stock | 12153 | $17.84 | 228,100.0000 | 0 | 5.06% | 0.00% |
| March 18, 2024 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | S | Common Stock | 1296 | $18.62 | 226,804.0000 | 0 | 0.57% | 0.00% |
| Feb. 26, 2024 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | S | Common Stock | 24555 | $20.07 | 274,323.0000 | 0 | 8.22% | 0.00% |
| Feb. 27, 2024 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | S | Common Stock | 34070 | $20.11 | 240,253.0000 | 0 | 12.42% | 0.00% |
| Feb. 7, 2024 | Syndax Pharmaceuticals Inc | $SNDX | Jarrett Jennifer | Not found | A | Common Stock | 17000 | $0.00 | 65,000.0000 | 0 | 35.42% | 0.00% |
| Jan. 23, 2024 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | A | Common Stock | 40000 | $0.00 | 298,878.0000 | 0 | 15.45% | 0.00% |
| Jan. 23, 2024 | Arcus Biosciences, Inc. | $RCUS | Jarrett Jennifer | Chief Operating Officer | A | Stock Option (right to buy) | 162400 | $0.00 | 162,400.0000 | 0 | 9999.99% | 0.00% |
| Feb. 2, 2023 | Syndax Pharmaceuticals Inc | $SNDX | Jarrett Jennifer | Not found | A | Common Stock | 16000 | $0.00 | 48,000.0000 | 0 | 50.00% | 0.00% |